PT87061A - Procede de preparation de nouveaux derives de la morpholine - Google Patents
Procede de preparation de nouveaux derives de la morpholineInfo
- Publication number
- PT87061A PT87061A PT87061A PT8706188A PT87061A PT 87061 A PT87061 A PT 87061A PT 87061 A PT87061 A PT 87061A PT 8706188 A PT8706188 A PT 8706188A PT 87061 A PT87061 A PT 87061A
- Authority
- PT
- Portugal
- Prior art keywords
- morpholine
- procede
- preparation
- aralkyl
- acyl
- Prior art date
Links
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 title 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000302 ischemic effect Effects 0.000 abstract 1
- 150000002780 morpholines Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Earth Drilling (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Control For Baths (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8704047A FR2612926B1 (fr) | 1987-03-24 | 1987-03-24 | Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT87061A true PT87061A (pt) | 1988-04-01 |
| PT87061B PT87061B (pt) | 1992-07-31 |
Family
ID=9349348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT87061A PT87061B (pt) | 1987-03-24 | 1988-03-23 | Processo para a preparacao de novos derivados da morfolina |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4782054A (pt) |
| EP (1) | EP0286495B1 (pt) |
| JP (1) | JPH0657709B2 (pt) |
| AT (1) | ATE89281T1 (pt) |
| AU (1) | AU600209B2 (pt) |
| CA (1) | CA1313870C (pt) |
| DE (1) | DE3880874T2 (pt) |
| DK (1) | DK171580B1 (pt) |
| ES (1) | ES2006390A6 (pt) |
| FR (1) | FR2612926B1 (pt) |
| GR (1) | GR1000241B (pt) |
| HK (1) | HK57297A (pt) |
| IE (1) | IE61882B1 (pt) |
| NZ (1) | NZ223984A (pt) |
| OA (1) | OA08822A (pt) |
| PT (1) | PT87061B (pt) |
| ZA (1) | ZA882107B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2653999A1 (fr) * | 1989-11-06 | 1991-05-10 | Adir | Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
| US6048859A (en) | 1992-06-29 | 2000-04-11 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
| US5719147A (en) * | 1992-06-29 | 1998-02-17 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
| US5637699A (en) * | 1992-06-29 | 1997-06-10 | Merck & Co., Inc. | Process for preparing morpholine tachykinin receptor antagonists |
| IL112778A0 (en) * | 1994-03-04 | 1995-05-26 | Merck & Co Inc | Substituted heterocycles, their preparation and pharmaceutical compositions containing them |
| GB0409744D0 (en) * | 2004-04-30 | 2004-06-09 | Pfizer Ltd | Novel compounds |
| AP2006003771A0 (en) * | 2004-04-30 | 2006-10-31 | Warner Lambert Co | Substituted morpholine compounds for the treatmentof central nervous system disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1138405A (en) * | 1966-12-28 | 1969-01-01 | Ici Ltd | Morpholine derivatives |
| BE758766A (fr) * | 1969-11-17 | 1971-05-10 | Ici Ltd | Nouveaux derives de la morpholine et de la |
-
1987
- 1987-03-24 FR FR8704047A patent/FR2612926B1/fr not_active Expired
-
1988
- 1988-03-04 US US07/164,103 patent/US4782054A/en not_active Expired - Lifetime
- 1988-03-09 CA CA000561016A patent/CA1313870C/fr not_active Expired - Fee Related
- 1988-03-18 DK DK150088A patent/DK171580B1/da not_active IP Right Cessation
- 1988-03-23 GR GR880100179A patent/GR1000241B/el not_active IP Right Cessation
- 1988-03-23 JP JP63069198A patent/JPH0657709B2/ja not_active Expired - Lifetime
- 1988-03-23 DE DE88400693T patent/DE3880874T2/de not_active Expired - Fee Related
- 1988-03-23 AU AU13520/88A patent/AU600209B2/en not_active Ceased
- 1988-03-23 NZ NZ223984A patent/NZ223984A/xx unknown
- 1988-03-23 IE IE85188A patent/IE61882B1/en not_active IP Right Cessation
- 1988-03-23 EP EP88400693A patent/EP0286495B1/fr not_active Expired - Lifetime
- 1988-03-23 PT PT87061A patent/PT87061B/pt not_active IP Right Cessation
- 1988-03-23 AT AT88400693T patent/ATE89281T1/de active
- 1988-03-24 ES ES8800903A patent/ES2006390A6/es not_active Expired
- 1988-03-24 OA OA59308A patent/OA08822A/xx unknown
- 1988-03-24 ZA ZA882107A patent/ZA882107B/xx unknown
-
1997
- 1997-05-01 HK HK57297A patent/HK57297A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE3880874D1 (de) | 1993-06-17 |
| JPH0657709B2 (ja) | 1994-08-03 |
| AU1352088A (en) | 1988-09-22 |
| OA08822A (fr) | 1989-03-31 |
| DK150088A (da) | 1988-09-25 |
| PT87061B (pt) | 1992-07-31 |
| DK150088D0 (da) | 1988-03-18 |
| HK57297A (en) | 1997-05-09 |
| DE3880874T2 (de) | 1993-12-23 |
| IE880851L (en) | 1988-09-24 |
| ATE89281T1 (de) | 1993-05-15 |
| FR2612926B1 (fr) | 1989-06-09 |
| NZ223984A (en) | 1990-05-28 |
| GR1000241B (el) | 1992-05-12 |
| ZA882107B (en) | 1989-06-28 |
| EP0286495B1 (fr) | 1993-05-12 |
| EP0286495A1 (fr) | 1988-10-12 |
| JPS63255279A (ja) | 1988-10-21 |
| CA1313870C (fr) | 1993-02-23 |
| GR880100179A (en) | 1989-01-31 |
| FR2612926A1 (fr) | 1988-09-30 |
| IE61882B1 (en) | 1994-11-30 |
| DK171580B1 (da) | 1997-02-03 |
| ES2006390A6 (es) | 1989-04-16 |
| AU600209B2 (en) | 1990-08-02 |
| US4782054A (en) | 1988-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI883249A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi | |
| NZ223984A (en) | N,n 1 -substituted-morpholinylmethoxy-tetrahydroquinolines as pharmaceuticals | |
| DK119188D0 (da) | Substituerede pyridin-2,4-dicarboxylsyrederivater, fremgangsmaader til deres fremstilling samt laegemiddel indeholdende forbindelserne | |
| NO165393C (no) | Fremgansmaate for fremstilling av aryloksypropanolaminer og salter av disse med difenyleddiksyre. | |
| HUT48464A (en) | Process for producing pharmaceutical composition for treating hypertonia and cardiac failure | |
| AU631465B2 (en) | New morpholine derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them | |
| FR2703048B1 (fr) | Nouveaux composes n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant. | |
| GR3005466T3 (pt) | ||
| AU5608790A (en) | New pyrrolidone derivatives, the process for their preparation and the pharmaceutical compositions containing them | |
| CS53688A2 (en) | Method of new substituted 3-phenyl-7h-thiazolo/3,2-b//1,2,4/triazine -7-ons production | |
| DE3466877D1 (en) | Crystalline salts of l or (s)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process | |
| PT79200A (de) | Substituierte pyrido(1,2-c)imidazo(1,2-a)benzimidazole verfahren zu ihrer herstellung ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen | |
| DE59208954D1 (de) | Verfahren zur enzymatischen Herstellung isomerenreiner Isosorbid-2- und 5-monoester sowie deren Überführung in Isosorbid-2- und 5-nitrat | |
| AU2046888A (en) | Process for the preparation of n6-benzyloxycarbonyl-2,6- diaminopimelamic acid in the l, l or d, d or racemic forms | |
| FR2592653A1 (fr) | Derives de chromene, procede d'obtention et compositions pharmaceutiques. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG3A | Patent granted, date of granting |
Effective date: 19920115 |
|
| MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20020731 Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20020731 |